Introduced in North America through its Florastor® brand, Biocodex is a French family-owned pharmaceutical company that has grown from a pioneer to a major international player in the microbiota realm.
Since 1953, the company has been developing and marketing the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745.
In order to educate both health professionals and the general public, Biocodex provides, through the web platform "MicrobiotaEvents", the latest research, developments and scientific content in the field of microbiota.
Relevant content from each event is made available to MicrobiotaEvents community; to our community: videos and downloadable documents including abstracts, presentations, studies, etc. and expert interviews.
The history of Biocodex started in 1923 with the discovery of the yeast Saccharomyces boulardii CNCM I-745® in Indochina by Henri Boulard. In 1953, the Hublot and Vallet families acquired the rights to Henri Boulard’s yeast strain and fermentation process launching Biocodex.
Today, Biocodex has transformed itself, expanding its development around three pillars, microbiota, women’s heath, and orphan drugs...